Alpha DNA Investment Management’s Salesforce CRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,963
Closed -$1.39M 169
2023
Q1
$1.39M Buy
+6,963
New +$1.18M 0.41% 50
2021
Q4
Sell
-6,412
Closed -$1.74M 114
2021
Q3
$1.74M Buy
+6,412
New +$1.63M 1.18% 6
2021
Q2
Sell
-4,177
Closed -$884K 211
2021
Q1
$884K Buy
4,177
+1,475
+55% +$328K 1.02% 18
2020
Q4
$601K Buy
+2,702
New +$657K 0.64% 73

Other funds holding CRM

Alpha DNA Investment Management's CRM Position: Q2 2023 in Review

Alpha DNA Investment Management sold out of Salesforce (CRM) in Q2 2023, closing a stake of 6,963 shares — an estimated $1.39M sold.

Alpha DNA Investment Management first reported a position in CRM in Q4 2020 and held it in 4 quarters. The position peaked at $1.74M in Q3 2021. 2,294 funds tracked by Wall St. Rank hold CRM as of Q2 2023.

  • Alpha DNA Investment Management reported no remaining Salesforce position as of Q2 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 6,963 Salesforce shares in Q2 2023, an estimated $1.39M.
  • Alpha DNA Investment Management first reported a position in Salesforce in Q4 2020 and held it in 4 quarters.
  • Alpha DNA Investment Management's Salesforce position peaked at $1.74M in Q3 2021.
  • 2,294 funds tracked by Wall St. Rank held Salesforce as of Q2 2023.

Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.